Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

Community pharmacy key to neighbourhood health, but investment needed, says CCA chief

Think-tank Reform emphasises that community pharmacies are more likely to be situated in areas of high deprivation and see patients more than anyone else in the primary care system.

Community pharmacy needs investment and support to deliver neighbourhood health, says CCA chief

Community pharmacies see patients more than anyone else in the primary care system.

Getty Images

Community pharmacies can play a vital role in delivering a ‘neighbourhood health service’, provided they receive the necessary investment and support, according to Malcolm Harrison, chief executive of the Company Chemists’ Association (CCA).

Harrison's comments come in response to a new report from think tank Reform, titled Designing a Neighbourhood Health Service, which outlines key principles for achieving the government's vision of a more community-focused healthcare system.


The report highlighted the significant contribution that community pharmacies can make in shifting care away from hospitals and into local communities.

“To be effective, Neighbourhood Health must be grounded in close partnership between health providers in a local area, but also between community leaders and the full breadth of organisations that operate at this scale, and which have a strong understanding of their communities: including local authorities, pharmacies, faith groups, local businesses and the VCFSE sector,” the report said.

The report emphasised the accessibility and reach of community pharmacies, particularly in areas of high deprivation.

It noted that over 93 per cent of patients living in areas of highest deprivation live within a mile of a pharmacy, compared to 71 per cent in areas of lowest deprivation.

Furthermore, the report emphasised that high street healthcare providers, such as community pharmacies, are more likely to employ practitioners who “reflect the demographics of the communities they serve” and see patients “more than anyone else in the primary care system (e.g. through their retail offer and unplanned drop-ins).”

“The median number of visits to a pharmacy is much higher, on average, than the median number of visits to general practice each year,” it stated.

Harnessing community pharmacy

Harrison welcomed the report as a timely recognition of “the huge potential to harness community pharmacy to deliver effective neighbourhood health.”

“With more pharmacies in more deprived communities, a workforce typically drawn from nearby neighbourhoods and highly trusted by patients, the community pharmacy network is ideally placed to improve health outcomes,” he said.

The government has set plans to move care closer to the community and shift from treating sickness to preventing ill health.

Harrison urged the Department of Health and NHS England to adopt the report’s proposed “actionable steps” to realise these shifts and provide pharmacies with the investment and backing they need to fulfil their role in a Neighbourhood Health Service.

Challenges

The report also acknowledged key challenges in delivering a truly integrated neighbourhood health system.

One major issue is data sharing between different healthcare providers.

The report noted that in many parts of the health system, there are “long-standing challenges around data controllership and how data is shared between organisations – particularly general practice and other providers of primary care like community pharmacy, optometry, audiology and dentistry.”

“Whilst GPs currently have controllership of data, it is imperative that other partners within primary care can also use data to support and configure services around population groups,” the report noted.

For example, the report cited a project where loyalty card data was used to predict women at risk of ovarian cancer. Early results suggested that analysis of shopping habits at pharmacies and supermarkets could indicate early warning signs often missed by GPs.

“This example demonstrates that the places which individuals have frequent contact with, such as the local supermarket and pharmacy, may have the data and knowledge of their users which can be applied to improve health outcomes,” it added.

The report argued that current neighbourhood-level health strategies are dominated by Primary Care Networks, which tend to take a “top-down and GP-led approach”, to the detriment of other primary care practitioners, such as dentists, pharmacists, audiologists and optometrists, as well as other organisations which contribute to population health at this level.

More For You

RPS group aims to tackle barriers holding back black pharmacy students

Work is underway to improve inclusivity in teaching

Pic credit: iStock

RPS group aims to tackle barriers holding back black pharmacy students

A cross-sector group aimed at tackling barriers that block the progression of black students and trainee pharmacists held its first meeting this week.

The Royal Pharmaceutical Society (RPS) has created the Differential Attainment Oversight Group to address issues that black or black British African student pharmacists and foundation trainees face such as limited access to work experience, financial support and visible role models in education and training.

Keep ReadingShow less
Older adult organizing medicine bottles in a cool, dry storage area during warm weather.

People are being advised to keep medicine below 25° C

Pic credit: iStock

Pharmacies advise patients on storing medicines safely during heatwave

Patients are being given important advice and guidance on the impact heat can have on their medicine and where to keep different medicines as the UK goes through a heatwave.

People are being advised to keep medicine below 25° C if they are able to, unless storage instructions state it needs to be kept at an alternative temperature, such as drugs that need to be refrigerated.

Keep ReadingShow less
Astrazeneca Office Building  Outlook

British Medical Journal has found data discrepancy during the crucial clinical trials of AstraZeneca's heart drug ticagrelor.

iStock

Top medics question trials of AstraZeneca's anti-clotting pill

The effectiveness of anti-clotting pill ticagrelor is now under a cloud, with some experts claiming that AstraZeneca misreported data when the trials were conducted more than a decade ago.

Sold as Brilinta, the pill was approved for use on the NHS in 2011 after trials claimed it could prevent one in five deaths after a heart attack, and the generic versions of the drug are scheduled for this year.

Keep ReadingShow less
Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

iStock

Pensions Ombudsman probing Boots pension dispute

The Pensions Ombudsman has begun an investigation into the decision by the Trustees of Boots Pension Scheme to remove members' option to retire on an unreduced pension at age 60.

According to the Pharmacists' Defence Association (PDA), the ombudsman has decided to take a ‘lead case’ approach, as several members have been affected by the issue.

Keep ReadingShow less
23andMe

More than 150,000 UK residents had their personal information taken by hackers during a data breach in 2023.

iStock

UK watchdog fines 23andMe £2.31m for data breach

Genetic testing firm 23andMe has been fined £2.31 million by a UK watchdog over a 2023 data breach, when the personal information of seven million people across the world was stolen.

The Information Commissioner's Office (ICO) said the California-based company, which later filed for bankruptcy, failed to put adequate measures in place to secure sensitive user data.

Keep ReadingShow less